Plain-English translation of NCT05556642 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This is a research registry โ a database that collects information from patients with relapsed or refractory hepatoblastoma (a type of liver cancer that has come back or stopped responding to treatment). The study gathers medical records, imaging scans, lab results, and tumor tissue samples from all patients enrolled to help researchers better understand why some children's cancers return or resist treatment, and to develop better therapies in the future.
Hepatoblastoma that returns or stops responding to standard treatment is very difficult to manage, and doctors need better ways to predict which treatments will work for each child. By collecting detailed information and tissue samples from many patients in one place, researchers can study what makes these cancers stubborn and test new approaches to fight them.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join, you'll give permission for the research team to collect your medical records, pathology reports, imaging scans, and tumor tissue samples (from surgery, biopsy, or other procedures you've already had or will have as part of your regular care). You may also be asked to donate blood, urine, or saliva samples at the time you enroll and again if your cancer returns. All this information goes into a secure database and may be used for future research to test new drugs or understand your cancer better โ but you can choose which parts you're comfortable sharing.
AI-generated summary from trial data ยท Jun 4, 2026 ยท Not medical advice
United States